HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma—A Tale of Two Proteins: Tax and HBZ
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
HTLV-1 (Human T-cell lymphotropic virus type 1) is a complex human delta retrovirus that currently infects 10–20 million people worldwide. While HTLV-1 infection is generally asymptomatic, 3%–5% of infected individuals develop a highly malignant and intractable T-cell neoplasm known as adult T-cell leukemia/lymphoma (ATL) decades after infection. How HTLV-1 infection progresses to ATL is not well understood. Two viral regulatory proteins, Tax and HTLV-1 basic zipper protein (HBZ), encoded by the sense and antisense viral transcripts, respectively, are thought to play indispensable roles in the oncogenic process of ATL. This review focuses on the roles of Tax and HBZ in viral replication, persistence, and oncogenesis. Special emphasis is directed towards recent literature on the mechanisms of action of these two proteins and the roles of Tax and HBZ in influencing the outcomes of HTLV-1 infection including senescence induction, viral latency and persistence, genome instability, cell proliferation, and ATL development. Attempts are made to integrate results from cell-based studies of HTLV-1 infection and studies of HTLV-1 proviral integration site preference, clonality, and clonal expansion based on high throughput DNA sequencing. Recent data showing that Tax hijacks key mediators of DNA double-strand break repair signaling—the ubiquitin E3 ligase, ring finger protein 8 (RNF8) and the ubiquitin E2 conjugating enzyme (UBC13)—to activate the canonical nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB) and other signaling pathways will be discussed. A perspective on how the Tax-RNF8 signaling axis might impact genomic instability and how Tax may collaborate with HBZ to drive oncogenesis is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Gessain, A., & Cassar, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00388 · Cited by 1,428 · cited 1×
“Human T-cell lymphotropic virus type 1 (HTLV-1) is a complex human delta retrovirus that infects 10–20 million people worldwide [1].”
BackgroundHuman T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829
Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton
Igakura, T., Stinchcombe, J. C., Goon, P. K. C., Taylor, G. P., Weber, J. N., Griffiths, G. M., Tanaka, Y., Osame, M., & Bangham, C. R. M. (2003) · Science · doi:10.1126/science.1080115 · Cited by 755
Pais-Correia, A.-M., Sachse, M., Guadagnini, S., Robbiati, V., Lasserre, R., Gessain, A., Gout, O., Alcover, A., & Thoulouze, M.-I. (2010) · Nature Medicine · doi:10.1038/nm.2065 · Cited by 344 · cited 1×
“HTLV-1 viral particles have also been found to be stored as carbohydrate-rich, biofilm-like extracellular assemblies that rapidly attach to target cells for virus transmission [38].”
BackgroundHTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
Satou, Y., Yasunaga, J.-I., Zhao, T., Yoshida, M., Miyazato, P., Takai, K., Shimizu, K., Ohshima, K., Green, P. L., Ohkura, N., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001274 · Cited by 319 · cited 1×
“Importantly, CD4+ T lymphocyte-specific expression of the HBZ transgene in mice induces T-cell lymphoma and systemic inflammation [8].”
BackgroundCell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4+ T cells
Jones, K. S., Petrow-Sadowski, C., Huang, Y. K., Bertolette, D. C., & Ruscetti, F. W. (2008) · Nature Medicine · doi:10.1038/nm1745 · Cited by 284 · cited 1×
“Interestingly, it has been shown recently that dendritic cells exposed to free HTLV-1 particles not only become productively infected themselves (cis-infection), but can also rapidly transmit the virus to CD4+ T-cells (trans-infection) [34–36] (reviewed in [37]).”
BackgroundHoenicke, L., & Zender, L. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs124 · Cited by 248 · cited 2×
“cells, neutrophils, and macrophages, for their clearance (reviewed in [81]).”
BackgroundMazurov, D., Ilinskaya, A., Heidecker, G., Lloyd, P., & Derse, D. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000788 · Cited by 217
Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms
Taniguchi, Y., Nosaka, K., Yasunaga, J.-I., Maeda, M., Mueller, N., Okayama, A., & Matsuoka, M. (2005) · Retrovirology · doi:10.1186/1742-4690-2-64 · Cited by 209
Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation
Arnold, J., Zimmerman, B., Li, M., Lairmore, M. D., & Green, P. L. (2008) · Blood · doi:10.1182/blood-2008-04-154286 · Cited by 207 · cited 1×
“Indeed, multiple lines of evidence support the notion that HBZ can promote “latently” infected cells to proliferate, and by so doing expand the reservoir of T-cells harboring the proviral genome [9,10].”
BackgroundDerse, D., Hill, S. A., Lloyd, P. A., Chung, H.-K., & Morse, B. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8461-8468.2001 · Cited by 145 · cited 1×
“HTLV-1 infection in cell culture is usually achieved by co-cultivation of naïve PBMCs with mitotically inactivated HTLV-1-producing cells [58,59] or by cell-free infection using vesicular stomatitis virus (VSV) G-pseudotyped viral particles [30].”
MethodNejmeddine, M., Negi, V. S., Mukherjee, S., Tanaka, Y., Orth, K., Taylor, G. P., & Bangham, C. R. M. (2009) · Blood · doi:10.1182/blood-2008-03-136770 · Cited by 118
Barnard, A. L., Igakura, T., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2005) · Blood · doi:10.1182/blood-2004-07-2850 · Cited by 114
Jain, P., Manuel, S. L., Khan, Z. K., Ahuja, J., Quann, K., & Wigdahl, B. (2009) · Journal of Virology · doi:10.1128/jvi.01054-09 · Cited by 87
What we are learning on HTLV-1 pathogenesis from animal models
Dodon, M. D., Villaudy, J., Gazzolo, L., Haines, R., & Lairmore, M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00320 · Cited by 23 · cited 1×
“Of the animal models of HTLV-1 infection, the rabbit model is perhaps the most amenable to experimentation, although none of the human diseases associated with HTLV-1 infection have been recapitulated therein [64,65].”
Background
Cited by
Intratumoural microbiota: a new frontier in cancer development and therapy
Cao, Y., Xia, H., Tan, X., Shi, C., Ma, Y., Meng, D., Zhou, M., Lv, Z., Wang, S., & Jin, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01693-0 · Cited by 253
Futsch, N., Mahieux, R., & Dutartre, H. (2017) · Viruses · doi:10.3390/v10010001 · Cited by 155
Omsland, M., Pise-Masison, C., Fujikawa, D., Galli, V., Fenizia, C., Parks, R. W., Gjertsen, B. T., Franchini, G., & Andresen, V. (2018) · Scientific Reports · doi:10.1038/s41598-018-29391-w · Cited by 71
Baratella, M., Forlani, G., Raval, G. U., Tedeschi, A., Gout, O., Gessain, A., Tosi, G., & Accolla, R. S. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005285 · Cited by 42
Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
Soltani, A., Hashemy, S. I., Zahedi Avval, F., Soleimani, A., Rafatpanah, H., Rezaee, S. A., Griffith, R., & Mashkani, B. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.139 · Cited by 31
Metadata
- Authors
- Giam, C.-Z., & Semmes, O.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2016-06-16
- Volume
- 8
- Issue
- 6
- Pages
- 161
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2444199844
- Cited by
- 162
- References
- 17
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.